Crossmark

A biopolymer-based and inflammation-responsive nanodrug for rheumatoid arthritis treatment <i>via</i> inhibiting JAK-STAT and JNK signalling pathways

Crossref DOI link: https://doi.org/10.1039/D0NR05551D

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Wang, Ziqian

Zhan, Chenyue

Zeng, Fang https://orcid.org/0000-0002-6607-3494
Wu, Shuizhu https://orcid.org/0000-0002-6739-0694
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (21875069)

National Natural Science Foundation of China (51673066)

National Natural Science Foundation of China (21574044)

Natural Science Foundation of Guangdong Province (2016A030312002)
License Information

Accepted Manuscript valid from 2021-10-27
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Fang Zeng (ORCID)

: Shuizhu Wu (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 26 July 2020; Accepted 24 October 2020; Accepted Manuscript published 27 October 2020; Advance Article published 16 November 2020; Version of Record published 26 November 2020